PATENT CLAIM ANALYSIS

Application Number: 15874418
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "078180"]

Abstract:
The present invention is direct to a body-absorbable, mechanically hemostatic composition comprising a solid poloxamer having an average molecular weight of about 7,000 g/mol to about 15,000 g/mol, a high molecular weight dextran, optionally a fatty acid salt, and water, and a method for mechanically controlling the bleeding of bone comprising applying an effective amount of the composition to the affected area.

Claim (Index 22):
A package comprising the composition of  claim 19  or  20  wherein the composition is amorphous or in a generally rounded form or in a generally parallelepiped form, wherein said composition is sealed in an aseptic barrier package, and is sterile or sterilizable.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.51111
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14656032', '10941890', '10941889', '13173719', '11224650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7321809374836201
- 35 USC 102 Novelty (BERT): 0.5198473312740259
- Combined Prediction Score: 0.7109475768626607
- Mean Citation Score: 256.242158
- Max Citation Score: 330.228
- Similarity Product: 257.61940130710605

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test